WHITNEY MOORE: Open Payments
NPI 1164689071 · VANCLEAVE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 80 payments from 19 companies in 2025. Trend: 2023 $1,304 · 2024 $1,682 · 2025 $1,618
Food & beverage: $1,618
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $272 |
| ABBVIE INC. | 13 | $217 |
| Amgen Inc. | 9 | $150 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Axsome Therapeutics, Inc. | 5 | $119 |
| Lilly USA, LLC | 7 | $114 |
| PFIZER INC. | 5 | $97 |
| Abbott Laboratories | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| GlaxoSmithKline, LLC. | 4 | $72 |
Products named: Ozempic, QULIPTA, COBENFY, Auvelity, EVENITY, MOUNJARO, NURTEC ODT, FREESTYLE LIBRE 3.
Industry payments across MS — which companies pay providers there.
